1. Home
  2. NSPR vs VHC Comparison

NSPR vs VHC Comparison

Compare NSPR & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.20

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

N/A

Current Price

$13.45

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
VHC
Founded
2005
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
79.2M
IPO Year
2009
2008

Fundamental Metrics

Financial Performance
Metric
NSPR
VHC
Price
$1.20
$13.45
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
55.0K
15.0K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.99
EPS
N/A
N/A
Revenue
$2,310,000.00
$162,000.00
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3140.00
52 Week Low
$1.12
$6.60
52 Week High
$2.93
$29.00

Technical Indicators

Market Signals
Indicator
NSPR
VHC
Relative Strength Index (RSI) 27.44 42.48
Support Level N/A $12.95
Resistance Level $2.47 $18.26
Average True Range (ATR) 0.09 1.35
MACD -0.00 -0.13
Stochastic Oscillator 34.22 3.80

Price Performance

Historical Comparison
NSPR
VHC

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

Share on Social Networks: